Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 7
1994 19
1995 19
1996 44
1997 31
1998 64
1999 57
2000 58
2001 65
2002 77
2003 67
2004 84
2005 67
2006 81
2007 84
2008 94
2009 84
2010 90
2011 99
2012 112
2013 93
2014 94
2015 102
2016 107
2017 97
2018 69
2019 78
2020 71
2021 60
2022 21
Text availability
Article attribute
Article type
Publication date

Search Results

1,903 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Regulatory B cells in infection, inflammation, and autoimmunity.
Dasgupta S, Dasgupta S, Bandyopadhyay M. Dasgupta S, et al. Cell Immunol. 2020 Jun;352:104076. doi: 10.1016/j.cellimm.2020.104076. Epub 2020 Feb 27. Cell Immunol. 2020. PMID: 32143836 Review.
Emerging evidence suggests that TLR signalling component Myd88 impacts the modulation of Breg cell responses and the host's susceptibility to infection. Breg cells are found to reduce relapsing-remitting experimental autoimmune encephalomyelitis. However, the Breg- …
Emerging evidence suggests that TLR signalling component Myd88 impacts the modulation of Breg cell responses and the host's su …
B cell regulation in cancer and anti-tumor immunity.
Sarvaria A, Madrigal JA, Saudemont A. Sarvaria A, et al. Cell Mol Immunol. 2017 Aug;14(8):662-674. doi: 10.1038/cmi.2017.35. Epub 2017 Jun 19. Cell Mol Immunol. 2017. PMID: 28626234 Free PMC article. Review.
The balance between immune effector cells and immunosuppressive cells and how this regulates the tumor microenvironment has been well described. ...Bregs can suppress diverse cell subtypes, including T cells, through the secretion of anti-inflammatory mediators
The balance between immune effector cells and immunosuppressive cells and how this regulates the tumor microenvironment has be …
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.
Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning CJ, Aepfelbacher M, Heesemann J. Sing A, et al. J Exp Med. 2002 Oct 21;196(8):1017-24. doi: 10.1084/jem.20020908. J Exp Med. 2002. PMID: 12391013 Free PMC article.
LcrV is a released protein which is involved in contact-induced secretion of yersinia antihost proteins and in evasion of the host's innate immune response. Here we report that recombinant LcrV signals in a CD14- and toll-like r
LcrV is a released protein which is involved in contact-induced secretion of yersinia antihost proteins and in evasion of the host
Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers.
Shamji MH, Durham SR. Shamji MH, et al. J Allergy Clin Immunol. 2017 Dec;140(6):1485-1498. doi: 10.1016/j.jaci.2017.10.010. J Allergy Clin Immunol. 2017. PMID: 29221580 Free article. Review.
Immunotherapy results in the production of blocking IgG/IgG(4) antibodies that can inhibit IgE-dependent activation mediated through both high-affinity IgE receptors (FcepsilonRI) on mast cells and basophils and low-affinity IgE receptors (FcepsilonRII) on B …
Immunotherapy results in the production of blocking IgG/IgG(4) antibodies that can inhibit IgE-dependent activation mediated through …
Interleukin-10 mediated immune regulation after stem cell transplantation: Mechanisms and implications for therapeutic intervention.
Zhang P, Hill GR. Zhang P, et al. Semin Immunol. 2019 Aug;44:101322. doi: 10.1016/j.smim.2019.101322. Epub 2019 Oct 19. Semin Immunol. 2019. PMID: 31640914 Review.
Interleukin-10 (IL-10) is a multi-faceted anti-inflammatory cytokine which plays an essential role in immune tolerance. Indeed, deficiency of IL-10 or its receptor results in aberrant immune responses that lead to immunopath
Interleukin-10 (IL-10) is a multi-faceted anti-inflammatory cytokine which plays an essential role in immune
Suppression of antigen presentation by IL-10.
Mittal SK, Roche PA. Mittal SK, et al. Curr Opin Immunol. 2015 Jun;34:22-7. doi: 10.1016/j.coi.2014.12.009. Epub 2015 Jan 16. Curr Opin Immunol. 2015. PMID: 25597442 Free PMC article. Review.
IL-10 is an immunosuppressive cytokine that regulates immune responses by inhibiting the ability of APCs to present antigens to T cells in a variety of ways. The mechanisms of IL-10-mediated immunosuppression include interference i …
IL-10 is an immunosuppressive cytokine that regulates immune responses by inhibiting the ability of APCs to present …
Potential Targets to Mitigate Trauma- or Sepsis-Induced Immune Suppression.
Bergmann CB, Beckmann N, Salyer CE, Hanschen M, Crisologo PA, Caldwell CC. Bergmann CB, et al. Front Immunol. 2021 Feb 25;12:622601. doi: 10.3389/fimmu.2021.622601. eCollection 2021. Front Immunol. 2021. PMID: 33717127 Free PMC article.
Immunosuppressive cytokines play an essential role in mediating and upholding immunosuppression in these patients. Specifically, the cytokines Interleukin-10 (IL-10), Transforming Growth Factor-beta (TGF-beta) and Thymic stromal lymphopoi
Immunosuppressive cytokines play an essential role in mediating and upholding immunosuppression in these patients. Spec
B-cell regulation and its application to transplantation.
Clatworthy MR. Clatworthy MR. Transpl Int. 2014 Feb;27(2):117-28. doi: 10.1111/tri.12160. Epub 2013 Aug 4. Transpl Int. 2014. PMID: 23909582 Free article. Review.
There has been increasing interest in the role played by B cells and their associated antibody in the immune response to an allograft, driven by the need to undertake antibody-incompatible transplantation and evidence suggesting that B cells play a role in acute T-cell- …
There has been increasing interest in the role played by B cells and their associated antibody in the immune response to an allograft …
IL-10 as a Th2 Cytokine: Differences Between Mice and Humans.
Rasquinha MT, Sur M, Lasrado N, Reddy J. Rasquinha MT, et al. J Immunol. 2021 Nov 1;207(9):2205-2215. doi: 10.4049/jimmunol.2100565. J Immunol. 2021. PMID: 34663593 Review.
The discovery of IL-10 more than 30 years ago marked the beginning of our understanding of how cytokines regulate immune responses, based on cross-regulation between Th1 and Th2 cytokines. ...This notion is also supported by the discovery of regulatory T cells, whos …
The discovery of IL-10 more than 30 years ago marked the beginning of our understanding of how cytokines regulate immune respo …
[Interleukin-10 in dermatology].
Asadullah K, Döcke WD, Sabat R, Ebeling M, Volk HD, Sterry W. Asadullah K, et al. Hautarzt. 1999 Jan;50(1):12-9. doi: 10.1007/s001050050858. Hautarzt. 1999. PMID: 10068926 Review. German.
In additions cytokines are increasingly being used for therapeutic purposes, including dermatologic disorders. IL-10 is a recently described cytokine with anti-inflammatory and immunosuppressive qualities which plays an important role in immunoregulation. The overex …
In additions cytokines are increasingly being used for therapeutic purposes, including dermatologic disorders. IL-10 is a recently de …
1,903 results